ASHLEY BLACKSHARE: Open Payments
NPI 1548802077 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,217 in 54 payments from 18 companies in 2025. Trend: 2023 $1,952 · 2024 $2,186 · 2025 $1,217
Food & beverage: $1,217
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $209 |
| Janssen Biotech, Inc. | 12 | $208 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $117 |
| Sumitomo Pharma America, Inc. | 4 | $84 |
| PFIZER INC. | 4 | $81 |
| Agiliti Surgical, Inc. | 1 | $68 |
| Ferring Pharmaceuticals Inc. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Astellas Pharma US Inc | 3 | $49 |
| Boston Scientific Corporation | 2 | $45 |
Products named: BOTOX, ERLEADA, Xtandi, Nubeqa, Sonablate HIFU, ADSTILADRIN, PLUVICTO, ORGOVYX.
Industry payments across TX — which companies pay providers there.
